ALB and hepatocellular carcinoma: In the analysis of 1195 patients who did not develop HCC within 1 year and who were observed for more than 1 year, 43 patients developed HCC, and male sex (HR: 3.088), HA ≥75 ng/mL (HR: 3.300), EOT-AFP ≥5.3 ng/mL (HR: 3.288), and EOT-Alb <3.9 g/dL (HR: 2.289) were associated with the development of HCC (Table 4).